back pain after semaglutide exposure and its association with adverse outcomes in diabetic patients undergoing transforaminal lumbar interbody fusion for lumbar degenerative disc disease Does GLP-1 cause back pain?

Long-acting formulations, such as dulaglutide, liraglutide, and once-weekly exenatide, have consistently shown superior efficacy in reducing both fasting plasma glucose and HbA1c levels when compared to shorter-acting alternatives like twice-daily exenatide and lixisenatide (Htike et al

Selenocysteine-specific mass spectrometry reveals tissue-distinct selenoproteomes and candidate selenoproteins

Glutathione plays a central role in the body's natural detoxification processes

It is remarkably effective at creating a calorie deficit

For semaglutide users, being vigilant about these symptoms is essential

Many on GLP-1s have reported a significant reduction in (or outright elimination of) food noise, which drives cravings